(Q41433770)

30 September 2017

1 reference

title

Tourette syndrome. Clinical rating and quantitative assessment of tics (English)

1 reference

30 September 2017

Kompoliti K

1

1 reference

30 September 2017

Goetz CG

series ordinal

2

1 reference

30 September 2017

publication date

1 May 1997

1 reference

30 September 2017

1 reference

30 September 2017

volume

15

1 reference

30 September 2017

issue

2

1 reference

30 September 2017

page(s)

239-254

1 reference

A comprehensive psychopathological rating scale

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

The Leyton Obsessional Inventory-Child Version

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

A survey of Tourette syndrome patients and their families: the 1987 Ohio Tourette Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Videotape tic counts in the assessment of Tourette's syndrome: stability, reliability, and validity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Clonidine ameliorates Gilles de la Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

The Leyton Obsessional Inventory

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Effects of Dopamine Agonists and Antagonists in Tourette's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Methylphenidate in hyperactive boys with comorbid tic disorder: II. Short-term behavioral effects in school settings

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Talipexole and adult Gilles de la Tourette's syndrome: double-blind, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Clonidine and Gilles de la Tourette's syndrome: double-blind study using objective rating methods

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

A rating scale for Gilles de la Tourette's syndrome: description, reliability, and validity data

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

The Yale-Brown Obsessive Compulsive Scale. II. Validity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Normative data on revised Conners Parent and Teacher Rating Scales

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

A new instrument for clinical studies of Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Obsessional-compulsive complaints

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

The epidemiology of Tourette's syndrome: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Clonidine treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Observations and ratings of tics in school settings

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

An evaluation of behavioral treatments for Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

A comparison of pimozide and haloperidol in the treatment of Gilles de la Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

A children's global assessment scale (CGAS)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Controlled Study of Pimozide vs. Placebo in Tourette's Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Treatment of Gilles de la Tourette syndrome with pimozide

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Development of behavioral and emotional problems in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Cholinergic mechanisms in Tourette syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

Definitions and classification of tic disorders. The Tourette Syndrome Classification Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

The validity of instruments measuring tic severity in Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8619%2805%2970309-1

7 January 2021

10.1016/S0733-8619(05)70309-1

Identifiers

DOI

1 reference

30 September 2017

1 reference